Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy.
<h4>Background</h4>Chronic Chagas Cardiomyopathy (CCM) is a unique form of cardiomyopathy compared to other etiologies of heart failure. In CCM, risk prediction based on biomarkers has not been well-studied. We assessed the prognostic value of a biomarker panel to predict a composite out...
Guardado en:
Autores principales: | Luis E Echeverría, Lyda Z Rojas, Sergio Alejandro Gómez-Ochoa, Oscar L Rueda-Ochoa, Cristian David Sosa-Vesga, Taulant Muka, James L Januzzi, Rachel Marcus, Carlos A Morillo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e92f6727d6149eaaf213ed39a6d3eb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy
por: Luis E. Echeverría, et al.
Publicado: (2021) -
Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Luis E. Echeverría, et al.
Publicado: (2021) -
Predictors and prevention of diabetic cardiomyopathy
por: Chavali V, et al.
Publicado: (2013) -
GWAS loci associated with Chagas cardiomyopathy influences DNA methylation levels.
por: Desiré Casares-Marfil, et al.
Publicado: (2021) -
GWAS loci associated with Chagas cardiomyopathy influences DNA methylation levels
por: Desiré Casares-Marfil, et al.
Publicado: (2021)